Literature DB >> 14696300

Intestinal ischemia.

Bryan J Burns1, Lawrence J Brandt.   

Abstract

Ischemic injury to the gastrointestinal tract can threaten bowel viability with potential catastrophic consequences, including intestinal necrosis and gangrene. The presenting symptoms and signs are relatively nonspecific and diagnosis requires a high index of clinical suspicion. AMI often results from an embolus or thrombus within the SMA, although a low-flow state through an area of profound atherosclerosis may also induce severe ischemia. Because most laboratory and radiologic studies are nonspecific in early ischemia an aggressive approach to diagnosis with imaging of the splanchnic vasculature by mesenteric angiography is advocated. Various therapeutic approaches, including the infusion of vasodilators and thrombolytics, may then be used. Proper diagnosis and management of patients with AMI requires vigilance and a readiness to pursue an aggressive course of action.

Entities:  

Mesh:

Year:  2003        PMID: 14696300     DOI: 10.1016/s0889-8553(03)00093-1

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  15 in total

1.  Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yvette Leung; Stefan J Urbanski; Lynn Schindel; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

2.  Ischemic colitis: spectrum of CT findings, sites of involvement and severity.

Authors:  Cinthia Cruz; Hani H Abujudeh; Rosalynn M Nazarian; James H Thrall
Journal:  Emerg Radiol       Date:  2015-03-03

3.  Favorable response to subcutaneous administration of infliximab in rats with experimental colitis.

Authors:  John K Triantafillidis; Apostolos E Papalois; Aikaterini Parasi; Emmanuel Anagnostakis; Stavros Burnazos; Aristofanis Gikas; Emmanuel G Merikas; Emmanuel Douzinas; Maria Karagianni; Helen Sotiriou
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

4.  Impact of etiologic factors and APACHE II and POSSUM scores in management and clinical outcome of acute intestinal ischemic disorders after surgical treatment.

Authors:  Hui-Ping Hsu; Yan-Shen Shan; Yu-Hsiang Hsieh; Edgar D Sy; Pin-Wen Lin
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

5.  Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.

Authors:  Sherry D Fleming; Michael R Pope; Sara M Hoffman; Tiffany Moses; Urska Bukovnik; John M Tomich; Lynn M Wagner; Keith M Woods
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

6.  Triphasic CT in the diagnosis of acute mesenteric ischaemia.

Authors:  Nicola Schieda; Najla Fasih; Wael Shabana
Journal:  Eur Radiol       Date:  2013-03-08       Impact factor: 5.315

7.  Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

Authors:  Liudmila Kulik; Sherry D Fleming; Chantal Moratz; Jason W Reuter; Aleksey Novikov; Kuan Chen; Kathy A Andrews; Adam Markaryan; Richard J Quigg; Gregg J Silverman; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  Tempol reduces bacterial translocation after ischemia/reperfusion injury in a rat model of superior mesenteric artery occlusion.

Authors:  Ibrahim Berber; Cagatay Aydin; Nural Cevahir; Cigdem Yenisey; Gulistan Gumrukcu; Goksel Kocbil; Gurkan Tellioglu; Koray Tekin
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

9.  Intestinal histopathological changes in a porcine model of pneumoperitoneum-induced intra-abdominal hypertension.

Authors:  Ester Párraga Ros; Laura Correa-Martín; Francisco M Sánchez-Margallo; Irma Eugenia Candanosa-Aranda; Manu L N G Malbrain; Robert Wise; Rafael Latorre; Octavio López Albors; Gregorio Castellanos
Journal:  Surg Endosc       Date:  2018-05-17       Impact factor: 4.584

10.  Non-occlusive mesenteric ischemia and the role of cilostazol in its management.

Authors:  K A Sudharshana Murthy; H S Kiran; Vijay Cheluvaraj; Abhijit Bhograj
Journal:  J Pharmacol Pharmacother       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.